Effects of apelin-13 on rat bone marrow-derived mesenchymal stem cell proliferation through the AKT/GSK3β/Cyclin D1 Pathway

International Journal of Peptide Research and Therapeutics

Volumn 20, Issue 4, 2014, Pages 421-425

  Li, Lanfang ^a   Li, Lifang ^a   He, Lu ^a   Zhang, Zidong ^c   Xie, Feng ^a   Guo, Yu ^a   Xiao, Jianhua ^a   Chen, Linxi ^a   Li, Jian ^a,b  

^a UNIVERSITY OF SOUTH CHINA   (China)

^b BEIJING HOSPITAL   (China)

^c SAINT LOUIS UNIVERSITY   (United States)

Author keywords

Apelin; Bone marrow derived mesenchymal stem cells; Proliferation

Indexed keywords

EID: 84897352890     PISSN: 15733149     EISSN: 15733904     Source Type: Journal    
DOI: 10.1007/s10989-014-9404-1     Document Type: Article

References (19)

1. Barbash IM, Chouraqui P, Baron J, Feinberg MS, Etzion S, Tessone A, Miller L, Guetta E, Zipori D, Kedes LH, Kloner RA, Leor J (2003) Systemic delivery of bone marrow-derived mesenchymal stem cells to the infarcted myocardium: feasibility, cell migration, and body distribution. Circulation 108(7):863-868. doi: 10.1161/01.CIR.0000084828.50310.6A
2. Barnes G, Japp AG, Newby DE (2010) Translational promise of the apelin-APJ system. Heart 96(13):1011-1016. doi: 10.1136/hrt.2009.191122
3. Chang F, Lee JT, Navolanic PM, Steelman LS, Shelton JG, Blalock WL, Franklin RA, McCubrey JA (2003) Involvement of PI3K/Akt pathway in cell cycle progression, apoptosis, and neoplastic transformation: a target for cancer chemotherapy. Leukemia 17(3):590-603. doi: 10.1038/sj.leu.2402824
4. Charo DN, Ho M, Fajardo G, Kawana M, Kundu RK, Sheikh AY, Finsterbach TP, Leeper NJ, Ernst KV, Chen MM, Ho YD, Chun HJ, Bernstein D, Ashley EA, Quertermous T (2009) Endogenous regulation of cardiovascular function by apelin-APJ. Am J Physiol Heart Circ Physiol 297(5):H1904-H1913. doi: 10.1152/ajpheart.00686.2009
5. Gao LR, Xu RY, Zhang NK, Chen Y, Wang ZG, Zhu ZM, Fei YX, Cao Y, Xu HT, Yang Y (2009) Increased apelin following bone marrow mononuclear cell transplantation contributes to the improvement of cardiac function in patients with severe heart failure. Cell Transplant 18(12):1311-1318. doi: 10.3727/096368909X474843
6. Inui M, Fukui A, Ito Y, Asashima M (2006) Xapelin and Xmsr are required for cardiovascular development in Xenopus laevis. Dev Biol 298(1):188-200
7. Kasai A, Shintani N, Oda M, Kakuda M, Hashimoto H, Matsuda T, Hinuma S, Baba A (2004) Apelin is a novel angiogenic factor in retinal endothelial cells. Biochem Biophys Res Commun 325(2):395-400
8. Li F, Li L, Qin X, Pan W, Feng F, Chen F, Zhu B, Liao D, Tanowitz H, Albanese C, Chen L (2008) Apelin-induced vascular smooth muscle cell proliferation: the regulation of cyclin D1. Front Biosci J Virtual Libr 13:3786-3792
9. Li X, Zhang X, Li F, Chen L, Li L, Qin X, Gao J, Su T, Zeng Y, Liao D (2010) 14-3-3 Mediates apelin-13-induced enhancement of adhesion of monocytes to human umbilical vein endothelial cells. Acta Biochim Biophys Sin 42(6):403-409
10. Li L, Li F, Li F, Mao X, Yang L, Huang H, Guo Y, Chen L, Li J (2011) NOX4-derived reactive oxygen species drive apelin-13-induced vascular smooth muscle cell proliferation via the ERK pathway. Int J Pept Res Ther 17(4):307-315
11. Li L, Zeng H, Chen JX (2012) Apelin-13 increases myocardial progenitor cells and improves repair postmyocardial infarction. Am J Physiol Heart Circ Physiol 303(5):H605-H618. doi: 10.1152/ajpheart.00366.2012
12. Masri B, Lahlou H, Mazarguil H, Knibiehler B, Audigier Y (2002) Apelin (65-77) activates extracellular signal-regulated kinases via a PTX-sensitive G protein. Biochem Biophys Res Commun 290(1):539-545. doi: 10.1006/bbrc.2001.6230
13. Parrales A, Lopez E, López-Colomé A (2011) Thrombin activation of PI3K/PDK1/Akt signaling promotes cyclin D1 upregulation and RPE cell proliferation. Biochim Biophys Acta Mol Cell Res 1813(10):1758-1766
14. Paskaradevan S, Scott IC (2012) The Aplnr GPCR regulates myocardial progenitor development via a novel cell-non-autonomous, Galpha(i/o) protein-independent pathway. Biol Open 1(3):275-285. doi: 10.1242/bio.2012380
15. Rayalam S, Della-Fera MA, Kasser T, Warren W, Baile CA (2011) Emerging role of apelin as a therapeutic target in cancer: a patent review. Recent Pat Anti Cancer Drug Discov 6(3):367-372
16. Tatemoto K, Hosoya M, Habata Y, Fujii R, Kakegawa T, Zou MX, Kawamata Y, Fukusumi S, Hinuma S, Kitada C, Kurokawa T, Onda H, Fujino M (1998) Isolation and characterization of a novel endogenous peptide ligand for the human APJ receptor. Biochem Biophys Res Commun 251(2):471-476. doi: 10.1006/bbrc.1998.9489
17. Wang G, Anini Y, Wei W, Qi X, AM OC, Mochizuki T, Wang HQ, Hellmich MR, Englander EW, Greeley Jr. GH (2004) Apelin, a new enteric peptide: localization in the gastrointestinal tract, ontogeny, and stimulation of gastric cell proliferation and of cholecystokinin secretion. Endocrinology 145(3):1342-1348. doi: 10.1210/en.2003-1116
18. Yang W, Zhang Y, Li Y, Wu Z, Zhu D (2007) Myostatin induces cyclin D1 degradation to cause cell cycle arrest through a phosphatidylinositol 3-kinase/AKT/GSK-3β pathway and is antagonized by insulin-like growth factor 1. J Biol Chem 282(6):3799-3808
19. Ye X, Guo Y, Zhang Q, Chen W, Hua X, Liu W, Yang Y, Chen G (2013) BetaKlotho suppresses tumor growth in hepatocellular carcinoma by regulating Akt/GSK-3beta/cyclin D1 signaling pathway. PLoS One 8(1):e55615. doi: 10.1371/journal.pone.0055615